|
|
Article: FDA Approves Infrared Sciences' New BreastScan IR System for Early Detection of Breast Cancer.
- Article from:
- Business Wire
- Article date:
- February 26, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Feb. 26, 2004
Painless, Non-Invasive Procedure Improves the Chances
of Early Detection
Infrared Sciences Corporation (ISC) announced today that the U.S. Food and Drug Administration (FDA) has awarded 510k approval for the company's BreastScan IR(TM) - a new system utilizing digital infrared imaging to assist in the early detection of breast cancer.
"We're pleased with the FDA's approval of BreastScan IR, as the system is the most advanced infrared imaging system of its kind. It will be used to provide doctors with an automated, real-time report for use ...